Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective
作者： João Tomé‐Carneiro , Manuel Gonzálvez , Mar Larrosa , María J Yáñez‐Gascón , Francisco J García‐Almagro
DOI: 10.1111/NYAS.12150
关键词: Resveratrol 、 Heart disease 、 Disease 、 Clinical trial 、 Intensive care medicine 、 Biotechnology 、 Intervention (counseling) 、 Alternative medicine 、 Medicine 、 MEDLINE 、 Clinical significance 、 General Biochemistry, Genetics and Molecular Biology 、 History and philosophy of science
摘要: … from certain types of animal pharmacological studies to humans can be questionable. … above safety concerns. Also, fibrates, which are mainly indicated for patients with statin resistance …
harvard.edu
sci-hub.se 参考文章(76)
Pedram Kazemian, Seyyed M. R. Kazemi-Bajestani, Aws Alherbish, Justin Steed, Gavin Y. Oudit, The use of ω-3 poly-unsaturated fatty acids in heart failure: a preferential role in patients with diabetes. Cardiovascular Drugs and Therapy. ,vol. 26, pp. 311- 320 ,(2012) , 10.1007/S10557-012-6397-X
S. Renaud, M. de Lorgeril, Wine, alcohol, platelets, and the French paradox for coronary heart disease The Lancet. ,vol. 339, pp. 1523- 1526 ,(1992) , 10.1016/0140-6736(92)91277-F
Kuei-Chuan Chan, Hsi-Hsien Chou, Chien-Ning Huang, Ming-Chih Chou, Atorvastatin administration after percutaneous coronary intervention in patients with coronary artery disease and normal lipid profiles: impact on plasma adiponectin level. Clinical Cardiology. ,vol. 31, pp. 253- 258 ,(2008) , 10.1002/CLC.20181
María Azorín‐Ortuño, María J Yáñez‐Gascón, Fernando Vallejo, Francisco J Pallarés, Mar Larrosa, Ricardo Lucas, Juan C Morales, Francisco A Tomás‐Barberán, María T García‐Conesa, Juan C Espín, None, Metabolites and tissue distribution of resveratrol in the pig Molecular Nutrition & Food Research. ,vol. 55, pp. 1154- 1168 ,(2011) , 10.1002/MNFR.201100140
Hong Wang, Yue-Jin Yang, Hai-Yan Qian, Qian Zhang, Hui Xu, Jian-Jun Li, None, Resveratrol in cardiovascular disease: what is known from current research? Heart Failure Reviews. ,vol. 17, pp. 437- 448 ,(2012) , 10.1007/S10741-011-9260-4
S Gupta, SANDEEP Gupta, Inflammation, Atherosclerosis, and Coronary Artery Disease The New England Journal of Medicine. ,vol. 352, pp. 1685- 1695 ,(2005) , 10.1056/NEJMRA043430
J. R. Banegas, E. Lopez-Garcia, J. Dallongeville, E. Guallar, J. P. Halcox, C. Borghi, E. L. Masso-Gonzalez, F. J. Jimenez, J. Perk, P. G. Steg, G. De Backer, F. Rodriguez-Artalejo, Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study European Heart Journal. ,vol. 32, pp. 2143- 2152 ,(2011) , 10.1093/EURHEARTJ/EHR080
Joao Tomé‐Carneiro, Manuel Gonzálvez, Mar Larrosa, Francisco J García‐Almagro, Francisco Avilés‐Plaza, Soledad Parra, María J Yáñez‐Gascón, José A Ruiz‐Ros, María T García‐Conesa, Francisco A Tomás‐Barberán, Juan Carlos Espín, None, Consumption of a grape extract supplement containing resveratrol decreases oxidized LDL and ApoB in patients undergoing primary prevention of cardiovascular disease: A triple‐blind, 6‐month follow‐up, placebo‐controlled, randomized trial Molecular Nutrition & Food Research. ,vol. 56, pp. 810- 821 ,(2012) , 10.1002/MNFR.201100673
Constantin Militaru, Ionut Donoiu, Alina Craciun, Iulia Daria Scorei, Anca Mihaela Bulearca, Romulus Ion Scorei, Oral resveratrol and calcium fructoborate supplementation in subjects with stable angina pectoris: Effects on lipid profiles, inflammation markers, and quality of life Nutrition. ,vol. 29, pp. 178- 183 ,(2013) , 10.1016/J.NUT.2012.07.006
Angela R. Subauste, Charles F. Burant, Role of FoxO1 in FFA-induced oxidative stress in adipocytes. American Journal of Physiology-endocrinology and Metabolism. ,vol. 293, pp. 159- 164 ,(2007) , 10.1152/AJPENDO.00629.2006